“Data on liver issues including liver cirrhosis, hepatocellular carcinoma, and hepatic failure in renal transplant patients with HCV infection are scarce. In the present study, we conducted a large-scale population-based analysis to investigate the long-term outcomes of renal recipients with HCV infection.”
Universal Emergency Room Hepatitis C Screening Finds More Cases
“Screening all adults who visit emergency department for hepatitis C virus (HCV), regardless of their risk profile, uncovered significantly more cases than a more targeted approach, according to study findings published in JAMA. But despite improved detection, only about 1 in 10 newly diagnosed patients ultimately started treatment and achieved a functional cure, underscoring persistent gaps in follow-up care.”
After Sustained HCV Virologic Response to DAAs, MASLD Increases HCC Risk
“Among patients with chronic hepatitis C virus (HCV), post-sustained virologic response (SVR) hepatocellular carcinoma (HCC) risk is significantly higher with metabolic dysfunction-associated steatotic liver disease (MASLD), according to study results published in the Journal of Gastroenterology.”
New European toolkit launched to help eliminate viral hepatitis B and C in prisons
“The European Union Drugs Agency (EUDA) and the European Centre for Disease Prevention and Control (ECDC) have jointly produced a European toolkit for the elimination of viral hepatitis in prisons. This new practical online resource, launched ahead of Prisoners’ Justice Day on 10 August, aims to support local efforts to eliminate viral hepatitis in prison settings, in accordance with the United Nations Sustainable Development Goal on Good Health and Well-Being.”
Successful treatment with DAAs nearly halved risk for renal, cognitive disorders in HCV
“Key takeaways: Incidence rates for most extrahepatic manifestations, including chronic kidney disease, were lower among patients successfully treated with DAAs vs. untreated patients. The exception was type 2 diabetes.”
